Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients
- PMID: 8112186
- DOI: 10.2337/diacare.17.1.30
Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients
Abstract
Objective: To examine the effects of caloric restriction, independent of differences in weight loss, on improvements in glycemic control, fasting insulin, and insulin sensitivity.
Research design and methods: We randomized 93 obese type II diabetic patients to two different degrees of calorie restriction (1,674 or 4,185 kJ/day; 400 or 1,000 kcal/day) and compared the changes in fasting glucose, fasting insulin, and insulin sensitivity that resulted from a comparable reduction in body weight (11% of initial body weight). Insulin sensitivity was assessed using the minimal model analysis of frequently sampled intravenous glucose tolerance tests.
Results: Despite equal weight losses, subjects in the 1,674 kJ/day (400 kcal) condition had lower fasting glucose levels (7.61 vs. 10.13 mM, P = 0.03) and greater insulin sensitivity (1.79 vs. 1.13, P = 0.04) after weight loss than did subjects in the 4,185 kJ/day (1,000 calorie) condition. Subjects were restudied 15 weeks later when both groups were consuming a 4,185 kJ/day (1,000 kcal/day) diet. Subjects who increased from 1,674 to 4,185 kJ (400 to 1,000 calories) had worse fasting glycemic control in spite of continued weight loss, whereas subjects who remained on 4,185 kJ (1,000 calories) throughout had further improvements in both blood glucose and insulin sensitivity with increased weight loss.
Conclusions: Both degree of calorie restriction and magnitude of weight loss have independent effects on improvements in glycemic control and insulin sensitivity.
Similar articles
-
The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM.Diabetes Care. 1998 May;21(5):687-94. doi: 10.2337/diacare.21.5.687. Diabetes Care. 1998. PMID: 9589225 Clinical Trial.
-
Effects of a behavioral weight loss program stressing calorie restriction versus calorie plus fat restriction in obese individuals with NIDDM or a family history of diabetes.Diabetes Care. 1995 Sep;18(9):1241-8. doi: 10.2337/diacare.18.9.1241. Diabetes Care. 1995. PMID: 8612437 Clinical Trial.
-
Potentiation of effects of weight loss by monounsaturated fatty acids in obese NIDDM patients.Diabetes. 1996 May;45(5):569-75. doi: 10.2337/diab.45.5.569. Diabetes. 1996. PMID: 8621005 Clinical Trial.
-
Use of very-low-calorie diets in the treatment of obese persons with non-insulin-dependent diabetes mellitus.J Am Diet Assoc. 1995 May;95(5):569-72; quiz 573-4. doi: 10.1016/S0002-8223(95)00155-7. J Am Diet Assoc. 1995. PMID: 7722192 Review.
-
Dietary considerations for obese diabetic subjects.Diabetes Care. 1988 Feb;11(2):183-8. doi: 10.2337/diacare.11.2.183. Diabetes Care. 1988. PMID: 3289866 Review.
Cited by
-
An introduction to insulin use in type 2 diabetes mellitus.S Afr Fam Pract (2004). 2023 Apr 20;65(1):e1-e5. doi: 10.4102/safp.v65i1.5702. S Afr Fam Pract (2004). 2023. PMID: 37132569 Free PMC article.
-
Chrononutrition-When We Eat Is of the Essence in Tackling Obesity.Nutrients. 2022 Nov 29;14(23):5080. doi: 10.3390/nu14235080. Nutrients. 2022. PMID: 36501110 Free PMC article. Review.
-
Randomized controlled trial of once-per-week intermittent fasting for health improvement: the WONDERFUL trial.Eur Heart J Open. 2021 Sep 3;1(2):oeab026. doi: 10.1093/ehjopen/oeab026. eCollection 2021 Sep. Eur Heart J Open. 2021. PMID: 35919268 Free PMC article.
-
Androgen Deprivation Therapy in High-Risk Localized and Locally Advanced Prostate Cancer.Cancers (Basel). 2022 Apr 1;14(7):1803. doi: 10.3390/cancers14071803. Cancers (Basel). 2022. PMID: 35406575 Free PMC article. Review.
-
Marginal Impact of Brown Seaweed Ascophyllum nodosum and Fucus vesiculosus Extract on Metabolic and Inflammatory Response in Overweight and Obese Prediabetic Subjects.Mar Drugs. 2022 Feb 26;20(3):174. doi: 10.3390/md20030174. Mar Drugs. 2022. PMID: 35323474 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical